Glucotrack (GCTK) Total Current Liabilities (2010 - 2025)

Glucotrack has disclosed Total Current Liabilities across 16 years of filings, most recently posting $4.8 million for Q4 2025.

• Quarterly Total Current Liabilities rose 274.35% year-over-year to $4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $4.8 million (up 274.35% YoY) and the FY2025 annual result came in at $4.8 million, up 274.35% from the prior year.
• Total Current Liabilities retreated to $4.8 million in Q4 2025, from $5.3 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $5.3 million in Q3 2025 and troughed at $883000.0 in Q4 2021.
• A 5-year average of $2.0 million and a median of $1.3 million in 2021 frame the typical range for Total Current Liabilities.
• Annual changes were most pronounced in 2021 — Total Current Liabilities slumped 37.09% — and 2025, when it soared 274.35%.
• Tracing GCTK's Total Current Liabilities over 5 years: stood at $883000.0 in 2021, then advanced by 14.72% to $1.0 million in 2022, then soared by 49.26% to $1.5 million in 2023, then dropped by 15.67% to $1.3 million in 2024, then surged by 274.35% to $4.8 million in 2025.
• Business Quant data shows GCTK's Total Current Liabilities at $4.8 million in Q4 2025, $5.3 million in Q3 2025, and $3.1 million in Q2 2025.